Aequus Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 0.008125
Aequus Pharmaceuticals' future price is the expected price of Aequus Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Aequus Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please specify Aequus Pharmaceuticals' target price for which you would like Aequus Pharmaceuticals odds to be computed.
Aequus |
Aequus Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aequus Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aequus Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aequus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aequus Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Aequus Pharmaceuticals has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 254.9 K. Net Loss for the year was (2.96 M) with profit before overhead, payroll, taxes, and interest of 2.69 M. | |
| Aequus Pharmaceuticals has accumulated about 1.46 M in cash with (2.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company shares are held by company insiders |
Aequus Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aequus Stock often depends not only on the future outlook of the current and potential Aequus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aequus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 132.6 M | |
| Cash And Short Term Investments | 215 K |
Aequus Pharmaceuticals Technical Analysis
Aequus Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Aequus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aequus Pharmaceuticals. In general, you should focus on analyzing Aequus Stock price patterns and their correlations with different microeconomic environments and drivers.
Aequus Pharmaceuticals Predictive Forecast Models
Aequus Pharmaceuticals' time-series forecasting models is one of many Aequus Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aequus Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Aequus Pharmaceuticals
Checking the ongoing alerts about Aequus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aequus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Aequus Pharmaceuticals is way too risky over 90 days horizon | |
| Aequus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aequus Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Aequus Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Aequus Pharmaceuticals has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 254.9 K. Net Loss for the year was (2.96 M) with profit before overhead, payroll, taxes, and interest of 2.69 M. | |
| Aequus Pharmaceuticals has accumulated about 1.46 M in cash with (2.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company shares are held by company insiders |
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.